Search

Sylvie Sim Phones & Addresses

  • 223 N 163Rd St, Omaha, NE 68118
  • La Vista, NE
  • Mountain View, CA
  • Dublin, CA
  • Lincoln, NE
  • Bellevue, NE
  • Ann Arbor, MI
  • La Vista, NE

Work

Company: University of nebraska medical center Sep 2010 Position: Biomedical engineer

Education

School / High School: University of Michigan 1997 to 2001

Skills

R&D • Cross Functional Team Leadership • Materials Science • Biomedical Engineering • Medical Devices • Fda • Biotechnology • Validation • Project Management • Cell Culture • Design of Experiments • Design Control • Spectroscopy • Lifesciences • Patents • Solidworks • Technology Transfer • Product Development • Gmp • Drug Delivery • Biomaterials • V&V • Capa

Industries

Medical Devices

Resumes

Resumes

Sylvie Sim Photo 1

Research Associate

View page
Location:
Omaha, NE
Industry:
Medical Devices
Work:
University of Nebraska Medical Center since Sep 2010
Biomedical Engineer

Guru Instruments, LLC Feb 2010 - Jul 2010
Consultant

QLT Inc. May 2007 - Aug 2009
Senior R&D Engineer

Covidien Jul 2005 - May 2007
R&D Materials Engineer

MC3, Inc. Feb 2003 - Aug 2004
Research Assistant
Education:
University of Michigan 1997 - 2001
Skills:
R&D
Cross Functional Team Leadership
Materials Science
Biomedical Engineering
Medical Devices
Fda
Biotechnology
Validation
Project Management
Cell Culture
Design of Experiments
Design Control
Spectroscopy
Lifesciences
Patents
Solidworks
Technology Transfer
Product Development
Gmp
Drug Delivery
Biomaterials
V&V
Capa

Publications

Us Patents

Lacrimal Implants And Related Methods

View page
US Patent:
20090104248, Apr 23, 2009
Filed:
Sep 8, 2008
Appl. No.:
12/231989
Inventors:
Alan R. Rapacki - Redwood City CA, US
Valery Rubinchik - Richmond, CA
John B. Holds - St. Louis MO, US
Sylvie Sim - Mountain View CA, US
Danny Shen - Stanford CA, US
Assignee:
QLT Plug Delivery, Inc. -QPDI - Menlo Park CA
International Classification:
A61F 9/00
US Classification:
424427
Abstract:
Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.

Composite Lacrimal Insert And Related Methods

View page
US Patent:
20100034870, Feb 11, 2010
Filed:
Apr 29, 2009
Appl. No.:
12/432553
Inventors:
Sylvie Sim - Mountain View CA, US
Rachna Jain - Milpitas CA, US
Kathleen Farinas - Los Altos CA, US
Assignee:
QLT. Plug Delivery, Inc. - Menlo Park CA
International Classification:
A61F 2/14
A61F 9/00
US Classification:
424427, 623 41, 156294
Abstract:
Lacrimal implants, methods of making lacrimal implants, and methods of treating ocular, respiration or other diseases or disorders using lacrimal implants are disclosed.

Sustained Release Delivery Of One Or More Agents

View page
US Patent:
20100209477, Aug 19, 2010
Filed:
Jan 22, 2010
Appl. No.:
12/692452
Inventors:
ZUHAL BUTUNER - Oakville, CA
Deepank Utkhede - Surrey, CA
Sylvie Sim - La Vista NE, US
David J. Wiseman - Surrey, CA
Assignee:
QLT PLUG DELIVERY INC. - Menlo Park CA
International Classification:
A61F 2/14
A61K 31/215
A61P 27/06
US Classification:
424427, 514530
Abstract:
The lacrimal implant delivery systems and methods described herein provide for controlled release of a therapeutic agent for the treatment of disease, including the treatment of glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agents. Treatment of disease, including glaucoma, ocular hypertension, or elevated intraocular pressure with latanoprost or other anti-glaucoma agent in conjunction with penetration enhancer, such as benzalkonium chloride, and/or artificial tears is also provided. Also provided are implants containing a drug core emplacable in a punctum adjacent to an eye of a patient for controlled release of a therapeutic agent such as latanoprost for the treatment of glaucoma, the drug core containing a polymer such as cross-linked silicone, a therapeutic agent, and an excipient, wherein the excipient can increase the rate of release of the agent from the drug core, or can increase the drug loading in the core without loss of desirable homogeneity of the agent within the core, or can improve retention of the agent in the eye or in tear fluid, or can increase corneal penetration of the agent into the eye.

Lacrimal Implant Body Including Comforting Agent

View page
US Patent:
20100274224, Oct 28, 2010
Filed:
Jul 8, 2009
Appl. No.:
12/499605
Inventors:
Rachna Jain - Milpitas CA, US
Robert W. Shimizu - Laguna Niguel CA, US
Alan R. Rapacki - Redwood City CA, US
Sylvie Sim - Omaha NE, US
Assignee:
QLT Plug Delivery, Inc. - Menlo Park CA
International Classification:
A61F 9/00
US Classification:
604514, 604285, 264319
Abstract:
Lacrimal implants for treating ocular diseases are disclosed. More particularly, lacrimal punctal plugs, methods of making such plugs, and methods of treating ocular diseases using such plugs are disclosed.

Lacrimal Implants And Related Methods

View page
US Patent:
20120318281, Dec 20, 2012
Filed:
Aug 29, 2012
Appl. No.:
13/598201
Inventors:
Alan R. Rapacki - Redwood City CA, US
Valery Rubinchik - Richmond, CA
John B. Holds - St. Louis MO, US
Sylvie Sim - Mountain View CA, US
Danny Shen - Stanford CA, US
Assignee:
QLT INC - Vancouver
International Classification:
A61F 9/00
US Classification:
128887
Abstract:
Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.

Lacrimal Implants And Related Methods

View page
US Patent:
20200030144, Jan 30, 2020
Filed:
Oct 7, 2019
Appl. No.:
16/594576
Inventors:
- Austin TX, US
Valery Rubinchik - Richmond, CA
John B. Holds - St. Louis MO, US
Sylvie Sim - Mountain View CA, US
Danny Shen - Stanford CA, US
Assignee:
Mati Therapeutics Inc. - Austin TX
International Classification:
A61F 9/00
A61F 9/007
Abstract:
Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.

Lacrimal Implants And Related Methods

View page
US Patent:
20180000642, Jan 4, 2018
Filed:
Sep 18, 2017
Appl. No.:
15/707386
Inventors:
- Austin TX, US
Valery Rubinchik - Richmond, CA
John B. Holds - St. Louis MO, US
Sylvie Sim - Mountain View CA, US
Danny Shen - Stanford CA, US
International Classification:
A61F 9/00
A61F 9/007
Abstract:
Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.

Lacrimal Implants And Related Methods

View page
US Patent:
20160361199, Dec 15, 2016
Filed:
Aug 25, 2016
Appl. No.:
15/247703
Inventors:
- Austin TX, US
Valery Rubinchik - Richmond, CA
John B. Holds - St. Louis MO, US
Sylvie Sim - Mountain View CA, US
Danny Shen - Stanford CA, US
International Classification:
A61F 9/00
A61F 9/007
Abstract:
Lacrimal implants for treating diseases or disorders are disclosed. More particularly, lacrimal implants, methods of making such implants, and methods of treating ocular, respiration, inner ear or other diseases or disorders using such implants are disclosed.
Sylvie L Sim from Omaha, NE, age ~45 Get Report